Go to navigation Go to content Ray Hodge & Associates, LLC
07/06/2017
Comments Off on Eliquis

Eliquis

Eliquis (apixaban) is an anticoagulant used to prevent the formation of blood clots. It is prescribed as an alternative to warfarin, because it is more convenient to use. Eliquis is marketed as a drug that can give you your freedom back, if you are tied down to routine blood monitoring and dietary restrictions because you take warfarin, but there is a catch. If you experience a serious bleeding event while taking Eliquis, there is no antidote. If you have been harmed by Eliquis bleeding or lost a loved one to an Eliquis bleeding event, please talk to the Kansas defective drug lawyers of Ray Hodge & Associates, LLC, right away.

Eliquis Injuries

Eliquis has been linked to serious side effects, some of which can cause permanent injury or death. Eliquis injuries can include:

• Stroke
• Bleeding in the brain
• Gastrointestinal bleeding
• Rectal bleeding
• Spinal bleeding
• Bleeding of the kidneys
• Bleeding in the eye
• Deep vein thrombosis (DVT)
• Formation of blood clots

Why is Eliquis Bleeding So Dangerous?

All blood thinners have the potential to cause serious bleeding events. Eliquis is a newer type of anticoagulant called novel oral anticoagulants (NOACs). NOACs were developed as an alternative to warfarin, which used to be the only choice. Warfarin requires routine blood monitoring and carries dietary restrictions. Patients find it inconvenient. Doctors can find it frustrating because patients do not always follow the rules. NOACs are supposed to make things easier on everyone.

There is a major trade-off. If you have a bleeding event while on warfarin, doctors can administer Vitamin K to reverse the anti-clotting action, so that the bleeding can be controlled. There is no reversal agent for Eliquis, and no way to get bleeding under control quickly.

Questionable Clinical Trial

Eliquis victims and their loved ones claim that at least one of the clinical trials, used as the basis for Eliquis approval, was fraudulent. The trial was called Apixaban for Reduction in Stroke and Other Thrombotic Events in Atrial Fibrillation (ARISTOTLE). The U.S. Food and Drug Administration (FDA) delayed approval of Eliquis due to errors and possible misconduct in ARISTOTLE, citing issues such as failure to report deaths and administration of the wrong drug, among other problems.

When the study was published in the New England Journal of Medicine, it came under fire from experts for its flaws.

If you have suffered a serious bleeding event while taking Eliquis, you may be able to recover substantial compensation for your injuries. Please, call Ray Hodge & Associates, LLC, at (316)269-1414 or contact us online right away to learn more.


Comments are closed.

Back to Top

Ray Hodge & Associates proudly represents victims and their families across the state of Kansas, including Wichita, Andover, Derby, Goddard, Haysville, Mulvane, Rose Hill, Newton, El Dorado and Hutchinson. Call today for a free consultation all over the state of Kansas. We have proudly served clients in Sedgwick, Butler, Sumner, Harvey, Kingman and Reno Counties.